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Scutellaria baicalensis Georgi from the Labiatae family is one of
the most famous crude drugs in traditional Chinese medicine
(TCM). In addition to the functions of clearing internal ﬁre,
removing damp-heat, and countering toxic pathogens according
to the theory TCM, it has also been reported to possess
antiallergic, antipyretic, antibacterial, antiviral, anticancer, and
anti-inﬂammatory properties in modern pharmacology1,2. Phyto-
chemically, S. baicalensis was documented to produce a large
spectrum of structurally-diverse metabolites, such as ﬂavonoids,
diterpenoids, phenol glycosides, and volatile components3–5, of
which, 2 new ﬂavonoids isolated from the EtOAc-soluble fraction
of the EtOH extract from the roots were recently reported by our
group6. As part of our ongoing effort to discover potential
bioactive natural compounds from Chinese medicinal plants, the
n-BuOH-soluble fraction of the EtOH extract from the roots was
also investigated systematically and, in addition to known com-
pounds, 3 new lignan glucosides were also obtained and identiﬁed.
The isolated compounds were tested for their anti-osteoporotic
activity in an in vitro osteoprotegerin (OPG) transcriptional
activity assay using dual luciferase reporter detection. This article
describes the isolation and structural determination of these new
compounds, and their anti-osteoporotic activity.2. Results and discussion
The neutral n-BuOH-soluble section of the EtOH extract from the
roots of S. baicalensis was subjected to multiple column chroma-
tographic puriﬁcation steps and further puriﬁed by preparative
HPLC, affording 3 new lignan glycosides (1–3) on top of some
known compounds. These new compounds were all identiﬁed as
lignan glycosides sharing 12 aromatic and 6 aliphatic carbons for
the lignan skeletons and 6 aliphatic carbons for the hexose unit
when removing the methoxy groups from the 13C and DEPT NMR
spectra. The hexose moiety of all the new compounds was
ascertained as D-glucopyranose with a β-glucosidic-bond linkage
by acid hydrolysis, derivatization reaction, and gas chromatogra-
phy (GC) analysis as described in Section 4.4, in conjunction with
comparison to the testing for authentic glucose under the same
condition, and by the splitting pattern of the doublet of the
anomeric protons sharing the coupling constants valued between
7.2 and 7.8 Hz in the 1H NMR spectra (Fig. 1 and Table 1). These
identiﬁcations were fully in accordance with the number of carbon
atoms in their respective molecular formulas obtained from the
HR-ESI-MS measurements (see Section 4).Figure 1 The structures of compounds 1–3.The molecular formula of compound 1 was determined as
C28H38O13 by
13C NMR analysis and by an HR-ESI-MS experi-
ment in the positive ion mode with the sodium adduct ion at
m/z 605.2202, indicating 10 indices of hydrogen deﬁciency. The
IR spectrum displayed absorption bands of hydroxy (3367 cm1),
aromatic (1614 and 1452 cm1), and etheric (1079 and
1046 cm1) functionalities. The 1H NMR spectrum exhibited
4 aromatic protons resonated in pairs as singlets at δH 6.46 (2H,
s, H-2/6) and 6.61 (2H, s, H-20/60), respectively, and 4 methoxy
groups also in pairs as singlets at δH 3.73 (6H, s, OMe-30/50) and
3.75 (6H, s, OMe-3/5), respectively. These features indicated the
existence of 2 symmetrically 1,3,4,5-tetrasubstituted benzene rings
on the numbering system of lignans. Except for the signals from
the glucose moiety which resonated at δH 4.86 (1H, d, J¼7.2 Hz,
H-1″), 3.06-3.22 (4H, m, H-2″, 3″, 4″, 5″), 3.43 (1H, dd, J¼12.6,
5.4 Hz, H-6″a), and 3.59 (1H, dd, J¼12.6, 2.4 Hz, H-6″b),
respectively, signals of a phenolic hydroxyl group at δH 8.08
(1H, s), a methylene at δH 2.43 (1H, dd, J¼13.2, 11.4 Hz, H-7a)
and 2.82 (1H, dd, J¼13.2, 4.8 Hz, H-7b), an methineoxy at δH
4.73 (1H, d, J¼6.0 Hz, H-70), 2 methines at δH 2.59 (1H, m, H-8)
and 2.26 (1H, dddd, J¼7.2, 7.2, 6.0, 6.0 Hz, H-80), and
2 methyleneoxys at δH 3.59 (1H, m, H-9a) and 3.92 (1H, dd,
J¼7.8, 6.6 Hz, H-9b) and δH 3.52 (1H, dd, J¼10.8, 7.2 Hz,
H-90a) and 3.72 (1H, ov, H-90b) were also evident in the 1H NMR
spectrum (Table 1), which were conﬁrmed by an HSQC experi-
ment. The 13C NMR spectrum of 1 showed 28 carbons which were
classiﬁed by the DEPT NMR experiment into 4 methyls, 4 methy-
lenes, 12 methines, 6 oxygenated aromatic tertiary carbons, and
2 aromatic quaternary carbons, with the aromatic, aliphatic, and
oxygenated carbons being categorized unequivocally by their
chemical shifts. The HMBC spectrum unambiguously established
the 2D structure of compound 1 as 40-(β-D-glucopyranosyloxy)-
3,30,5,50-tetramethoxy-9,90-epoxylignane-4,70-diol by the correla-
tions from H-2/6 to C-3/5, 4, and 7, from OH-4 to C-3/5 and 4,
from H2-7 to C-1, 2/6, 8, and 9, from H-20/60 to C-10, 30/50, 40, and
70, from H-70 to C-20/60, 80, and 90, from H-80 to C-10, 70, 8, and 90,
and from H-9b (δH 3.92) to C-7 and 80 (Fig. 2).
The molecular formula of compound 2 was established as
C27H36O12 by
13C NMR analysis and by an HR-ESI-MS experi-
ment in the positive ion mode with the sodium adduct ion at
m/z 575.2107, indicating 10 indices of hydrogen deﬁciency. The
IR spectrum displayed absorption bands of hydroxy (3396 cm1),
aromatic (1598 and 1468 cm1), and etheric (1239 and
1120 cm1) functionalities. An in-depth analysis of the NMR
data of 2, together with a comparison with those of 1, revealed that
compound 2 was very similar to 1 structurally. In the 1H NMR
spectrum, the main difference was that the set of resonances of the
symmetrically 1,3,4,5-tetrasubstituted benzene ring at δH 6.46 (2H,
s, H-2/6) in compound 1 was replaced by a set of resonances of a
1,3,4-trisubstituted benzene ring on the numbering system of
lignans at δH 6.76 (1H, d, J¼1.8 Hz, H-2), 6.69 (1H, d, J¼7.8 Hz,
H-5), and 6.60 (1H, dd, J¼7.8, 1.8 Hz, H-6), with 3 total
methoxyls only, in compound 2. In the 13C and DEPT NMR
spectra, the main difference was the appearance of an aromatic
methine at δC 115.3 (C-5) in 2 which replaced the oxygenated
tertiary aromatic carbon at δC 147.9 (C-5) in 1, with the downﬁeld
shifts of Δδ þ11.0 and þ14.6 from C-4 and C-6, respectively,
being observed (Table 1). Along with the HSQC spectrum, the
correlations from H-2 to C-1, 3, 4, 6, and 7; from OH-4 to C-3, 4,
and 5; from H-5 to C-1, 3, and 4; and from H-6 to C-2, 4, and 7 in
the HMBC spectrum conﬁrmed this assignment (Fig. 2). And the
HMBC correlations from H-20/60 to C-10, 30/50, 40, and 70, from H2
Table 1 1H and 13C NMR spectroscopic data for compounds 1–3.
No. 1 2 3
δH (mult. J, Hz) δC (DEPT) δH (mult. J, Hz) δC δH (mult. J in Hz) δC
1 130.9 s 131.6 s 131.6 s
2 6.46 s 105.9 d 6.76 d (1.8) 112.6 d 6.74 d (2.4) 112.6 d
3 147.9 s 147.4 s 147.3 s
4 133.5 s 144.5 s 144.5 s
5 147.9 s 6.69 d (7.8) 115.3 d 6.66 d (8.4) 115.3 d
6 6.46 s 105.9 d 6.60 dd (7.8, 1.8) 120.5 d 6.57 dd (8.4, 2.4) 120.5 d
7a 2.43 dd (13.2, 11.4) 32.6 t 2.43 dd (13.8, 10.8) 32.1 t 2.42 dd (13.8, 10.8) 32.0 t
7b 2.82 dd (13.2, 4.8) 2.80 dd (13.8, 4.8) 2.81 dd (13.8, 4.8)
8 2.59 m 41.9 d 2.58 m 42.0 d 2.57 m 41.8 d
9a 3.59 m 72.0 t 3.58 ov 72.0 t 3.57 dd (7.2, 7.2) 71.8 t
9b 3.92 dd (7.8, 6.6) 3.92 dd (7.8, 6.0) 3.89 dd (7.2, 7.2)
10 139.6 s 139.6 s 137.6 s
20 6.61 s 103.8 d 6.604 s 103.8 d 6.88 d (1.8) 109.9 d
30 152.4 s 152.4 s 148.6 s
40 133.6 s 133.4 s 145.4 s
50 152.4 s 152.4 s 7.02 d (8.4) 114.9 d
60 6.61 s 103.8 d 6.60 s 103.8 d 6.78 dd (8.4, 1.8) 117.6 d
70 4.73 d (6.0) 81.8 d 4.74 d (6.0) 81.8 d 4.71 d (6.0) 81.5 d
80 2.26 dddd (7.2, 7.2, 6.0, 6.0) 52.3 d 2.24 dddd (7.2, 7.2, 6.0, 6.0) 52.2 d 2.19 dddd (7.2, 7.2, 6.0, 6.0) 52.4 d
90a 3.52 dd (10.8, 7.2) 58.7 t 3.51 dd (10.8, 7.2) 58.7 t 3.48 m 58.5 t
90b 3.72 ov 3.71 dd (10.8, 7.2) 3.68 m
Glu-1 4.86 d (7.2) 102.7 d 4.86 d (7.8) 102.7 d 4.86 d (7.2) 100.0 d
Glu-2 3.22 m 74.1 d 3.22 m 74.2 d 3.26 m 73.1 d
Glu-3 3.22 m 76.5 d 3.22 m 76.5 d 3.26 m 76.8 d
Glu-4 3.16 m 69.9 d 3.16 m 69.9 d 3.16 m 69.6 d
Glu-5 3.06 m 77.1 d 3.06 m 77.1 d 3.26 m 76.9 d
Glu-6 3.43 dd (12.6, 5.4),
3.59 dd (12.6, 2.4)
60.9 t 3.44 dd (12.0, 6.0),
3.59 dd (12.0, 1.8)
60.9 t 3.43 dd (11.4, 5.4),
3.65 br d (11.4)
60.6 t
OMe-3 3.75 s 3.740 s 3.74 s
OMe-5 3.75 s
OMe-30 3.73 s 3.745 s 3.75 s
OMe-50 3.73 s 3.745 s
OH-4 8.08 s 8.69 s 8.68 s
Figure 2 Key HMBC correlations (H-C) of compounds 1–3.
Three new lignan glucosides from Scutellaria baicalensis 231-7 to C-1, 2, 6, 8, and 9, from H2-9 to C-7 and 80, and from H-70 to
10, 20/60, 8, 80, and 90 conﬁrmed unequivocally the 2D structure of
compound 2 as 40-(β-D-glucopyranosyloxy)-3,30,50-trimethoxy-
9,90-epoxylignane-4,70-diol.
The molecular formula of compound 3 was established as
C26H34O11 by
13C NMR data and by an HR-ESI-MS experiment
in the positive ion mode with the sodium adduct ion at
m/z 545.2002, indicating 10 indices of hydrogen deﬁciency.
The IR spectrum displayed absorption bands of hydroxy
(3395 cm1), aromatic (1598, 1515 and 1468 cm1), and
etheric (1238, 1125 and 1070 cm1) functionalities. A detailed
analysis of the NMR data of 3, along with a comparison with
those of 2, found that compound 3 was very similar to 2. In the
1H NMR spectrum, the main difference was that the set ofresonances of the symmetrically 10,30,40,50-tetrasubstituted ben-
zene ring at δH 6.604 (2H, s, H-20/60) in compound 2 was
replaced by a set of resonances of a 10,30,40-trisubstituted
benzene ring at δH 6.88 (1 H, d, J¼1.8 Hz, H-20), 7.02 (1 H,
d, J¼8.4 Hz, H-50), and 6.78 (1 H, dd, J¼8.4, 1.8 Hz, H-60),
with 2 methoxyls only being shown up in total, in compound 3.
In the 13C and DEPT NMR spectra, the main difference was the
appearance of an aromatic methine at δC 114.9 (C-50) in 3,
which replaced the oxygenated tertiary aromatic carbon at δC
152.4 (C-50) in 2, with the downﬁeld shifts of Δδ þ12.0 and
þ13.8 from C-40 and C-60, respectively, being observed. Along
with the HSQC spectrum, the correlations from H-20 to C-40, 60,
and 70; from H-50 to C-10, 30, and 40; and from H-60 to C-20, 40,
and 70 in the HMBC spectrum conﬁrmed this assignment
(Fig. 2). And the HMBC correlations from H-2 to C-4 and 6;
from OH-4 to C-3, 4, and 5; from H-5 to C-1, 3, and 4; from
H-6 to C-2 and 4; from H2-7 to C-1, 2, 6, 8, 80, and 9; from
H-70 to 10, 20, 60, 80, and 90; from H-80 to C-10, 70, 7, 8, 9,
and 90; from H2-9 to C-7, 8, and 80; and from H-glu-1″ to
C-40 conﬁrmed the 2D structure of compound 3 as
40-(β-D-glucopyranosyloxy)-3,30-dimethoxy-9,90-epoxylignane-4,70-
diol.
Even though it is well known that the establishment of the
relative conﬁgurations of saturated hetero 5-membered rings is
more complex than that for saturated hetero 6-membered rings, the
Hailin Long et al.232ﬁndings that the observed coupling constants of JH-9a/H-9b,
JH-9b/H-8, JH-90a/H-90b, JH-90a/H-80, JH-90b/H-80, and JH-80/H-70 of com-
pounds 1–3 were of the same magnitude among the counterparts,
respectively, of all the 3 molecules suggested that they have the
same steric arrangements (Table 1). These 1H NMR coupling
constants were also of the same magnitudes, respectively, as those
of their counterparts in tripterygiol, a known 3,4-dibenzyltetrahy-
drofuran-type lignan isolated previously from Tripterygium wil-
fordii, which possesses the same mono-hydroxyl substitution at the
70-position of the benzylidene group as compounds 1–37 do. So,
the relative conﬁgurations of the tetrahydrofuran moiety of
compounds 1–3 were all elucidated to be the same as that of
tripterygiol, that is, H-8 and H-80 were in the trans-orientations.
The absence of NOE correlation between H-8 and H-80 in the
NOESY spectrum of compound 3 conﬁrmed these assignments
(also, the NOE correlation of H-8/H-80 was hardly observed in the
1D NOE difference experiment, see Supplementary Information
Fig. S21), which is the same ﬁnding as that in the literature7. The
same value of JH-70/H-80 ¼6.0 Hz in all the 3 molecules conﬁrmed
that compounds 1–3 all possess the same relative conﬁguration for
the nonaromatic segments. Just because of the ambiguity involving
several effects, such as which of the 2 moieties constituting C
(8) and C(90) ligands linked to C(80) is larger in bulks than another,
the relative conﬁguration of C(70) is not clear, notwithstanding the
report for the conﬁguration assignment of a similar structure only
according to the JH-70/H-80 value
8. In this study, baicalensinosides
A–C were given as the trivial names of compounds 1–3,
respectively.
To evaluate the potential bioactivity, the cytotoxicity in MG63
cells was ﬁrst examined at 10 μmol/L using the MTT assay.
Compounds 1–3 showed no obvious cytotoxicity when incubated
with MG63 cells for 72 h (data not shown), suggesting that all the
compounds are suitable for studying additional bioactivities, such
as anti-osteoporotic activity. Compounds 1–3 were then evaluated
for their anti-osteoporotic activity in an in vitro OPG transcrip-
tional activity assay using dual luciferase reporter detection. This
target has been proven to play a critical role in regulating bone
remodeling9. Although OPG was closely related to the potential
treatment of osteoporosis, there has been no information as yet
regarding the application of OPG agonists as anti-osteoporotic
drug in clinic. Lack of a positive control compound led us to select
the pGL3-basic-vector control in this study. As a result, compound
1 showed moderate activity at the concentration of 10 μmol/L with
a relative activating ratio 1.83 times that of the control group.
Compounds 2 and 3 showed weaker inhibitory activity with a
relative activating ratio 0.84 and 0.98 times that of control group,
respectively.3. Conclusions
This study was conducted for the purpose of isolating and
identifying new naturally-occurring compounds, especially bioac-
tive compounds, from the roots of the titled plant. As a
consequence, 3 new compounds (1–3) were obtained. These new
compounds were identiﬁed as 3,4-dibenzyltetrahydrofuran-type
lignan glucosides with a mono-hydroxy substitution at the 70-
position of the benzylidene group using the lignans numbering
system being one of their shared critical features. Based on the
report on the anti-inﬂammatory and immunomodulatory activity of
the extract from the roots of the titled plant, the anti-osteoporotic
activity of all 3 compounds was assessed in an in vitro OPGtranscriptional activity assay using dual luciferase reporter detec-
tion. At 10 μmol/L, compounds 1–3 increased the relative activat-
ing ratio of OPG transcription to 1.83, 0.84 and 0.98 times that of
the control group, respectively.4. Experimental
4.1. General experimental procedures
Optical rotation was measured on a Perkin-Elmer 241 digital
polarimeter at a temperature of 20 1C. UV spectra were recorded
using a JASCO V-650 spectrophotometer, and IR (KBr) spectra
were recorded using a Nicolet 5700 spectrometer. 1D and 2D
NMR spectra were taken on a Varian Inova 600 MHz NMR
spectrometer using DMSO-d6 as a solvent and tetramethylsilane
(TMS) as an internal standard. Both ESI-MS and HR-ESI-MS
experiments were conducted on an Agilent 1100 series LC/MSD
Trap SL mass spectrometer. Preparative HPLC procedure was
performed on a Shimadzu LC-6AD instrument with a SPD-20A
detector and a reversed-phase C18 column (BDS HYPERSIL,
ODS-A, 250 mm 21.2 mm, particle size 5 μm; Thermo, CA,
USA). Silica gel (200–300 mesh; Qingdao Marine Chemical Inc.,
Qingdao, China), Diaion AB-8 (Chemical Plant of Nankai Uni-
versity, Tianjin, China), and Sephadex LH-20 (20–80 mm, Phar-
macia Fine Chemicals, Uppsala, Sweden) were used for column
chromatography (CC), and precoated GF254 silica gel plates
(Qingdao Marine Chemical Inc., Qingdao, China) was used for
TLC analyses. The spots were visualized by spraying with 10%
H2SO4 in aqueous 95% EtOH and followed by heating using a
hair dryer.
4.2. Plant material
The collection, identiﬁcation, and deposit of the roots of
S. baicalensis Georgi were described in our previous paper6.
4.3. Extraction and isolation
After the pretreatment of dried and pulverized roots of
S. baicalensis (18 kg) and the preliminary fractionation of the
EtOH extract from the roots as described in our previous paper has
served its intended purpose6, the remaining water solution was
extracted with n-BuOH for 3 times. Removal of the organic
solvent from the n-BuOH extract under reduced pressure led to a
brown semisolid residue (150 g). This residue was fractionated by
CC on Diaion AB-8, eluting sequentially with H2O, 20% aqueous
EtOH, 40% aqueous EtOH, 60% aqueous EtOH, and 80% aqueous
EtOH, to give 5 subfractions, Fr. 1 to Fr. 5, according to the
eluents. Fr. 3 (28.0 g; 40% aqueous EtOH) was separated by CC
on silica gel, using a gradient CHCl3–MeOH (100:0–50:1–25:1–
15:1–10:1–5:1) as an eluent, to yield 5 subfractions, Fr. 3-1 to Fr.
3–5, according to their TLC proﬁles. Fr. 3-2 (7.0 g; CHCl3
–MeOH, 50:1) was separated by CC on silica gel, using a gradient
CHCl3–MeOH (100:1–50:1–25:1–10:1) as an eluent, to yield
4 subfractions, Fr. 3-2-1 to Fr. 3-2-4. Fr. 3-2-3 (1.5 g; CHCl3
–MeOH, 25:1) was subjected to Sephadex LH-20 CC, using
MeOH as an eluent, to give 3 subfractions, Fr. 3-2-3-1 to Fr. 3-2-
3-3. Fr. 3-2-3-1 was puriﬁed by preparative RP-HPLC (mobile
phase of CH3CN–H2O (30%, v/v); ﬂow rate of 6 mL/min; and UV
detection at 210 and 280 nm, simultaneously) to afford 1 (7 mg; tR
Three new lignan glucosides from Scutellaria baicalensis 233¼35.5 min). Fr. 3-2-3-3 was puriﬁed by preparative RP-HPLC
(mobile phase of CH3CN–H2O (30%, v/v); ﬂow rate of 6 mL/min;
and UV detection at 210 and 280 nm, simultaneously) to afford 2
(5 mg; tR¼33.2 min). Fr. 3-3 (9.0 g; CHCl3–CH3OH, 25:1–15:1)
was separated by CC on silica gel, using a gradient CHCl3–MeOH
(50:1–25:1–15:1–10:1–5:1) as an eluent, to yield 5 subfractions,
Fr. 3-3-1 to Fr. 3-3-5. Fr. 3-3-1 (2.0 g; CHCl3–MeOH, 50:1) was
subjected to Sephadex LH-20 CC, using MeOH as an eluent, to
give 3 subfractions, Fr. 3-3-1-1 to Fr. 3-3-1-3. Fr. 3-3-1-1 was
puriﬁed by preparative RP-HPLC (mobile phase of CH3CN–H2O
(30%, v/v); ﬂow rate of 6 mL/min; and UV detection at 210 and
280 nm, simultaneously) to afford 3 (4 mg; tR¼29.6 min).
4.3.1. Baicalensinoside A (1)
White amorphous powder; [α]20D –28.5 (c 0.072, MeOH); UV
(MeOH) λmax (logε) 314 (2.96), 274 (3.10), 230 (3.99), 206
(4.66); IR (KBr) νmax 3367, 2922, 2852, 1614, 1452, 1079, 1046,
896, 701 cm1; 1H NMR (DMSO-d6, 600 MHz), see Table 1;
13C
NMR (DMSO-d6, 150 MHz) δ 56.4 (q, OMe-3/5), 55.9 (q, OMe-
30/50), and see Table 1 for other data; positive ion mode ESI-MS
m/z 605.3 [MþNa]þ; positive ion mode HR-ESI-MS m/z 605.2202
[MþNa]þ (Calcd. for C28H38NaO13, 605.2205).
4.3.2. Baicalensinoside B (2)
White amorphous powder; [α]20D –10.3 (c 0.081, MeOH); UV
(MeOH) λmax (logε) 277 (3.24), 230 (3.90), 204 (4.53); IR (KBr)
νmax 3396, 3190, 2938, 2922, 2850, 1647, 1598, 1468, 1426,
1239, 1120, 830, 721, 648 cm1; 1H NMR (DMSO-d6,
600 MHz), see Table 1; 13C NMR (DMSO-d6, 150 MHz) δ 56.3
(q, OMe-30/50), 55.5 (q, OMe-3), and see Table 1 for other data;
positive ion mode ESI-MS m/z 575.3 [MþNa]þ; positive ion mode
HR-ESI-MS m/z 575.2107 [MþNa]þ (Calcd. for C27H36NaO12,
575.2099).
4.3.3. Baicalensinoside C (3)
White amorphous powder; [α]20D –7.1 (c 0.24, MeOH); UV
(MeOH) λmax (logε) 279 (3.47), 226 (3.77), 210 (3.82); IR (KBr)
νmax 3395, 3195, 2921, 2850, 1647, 1598, 1515, 1468, 1421,
1238, 1125, 1070, 819, 721, 648 cm1; 1H NMR (DMSO-d6,
600 MHz), see Table 1; 13C NMR (DMSO-d6, 150 MHz) δ 55.5,
55.4 (2 q, OMe-3, 30), and see Table 1 for other data; positive
ion mode ESI-MS m/z 545.3 [MþNa]þ; positive ion mode HR-
ESI-MS m/z 545.2002 [MþNa]þ (Calcd. for C26H34NaO11,
545.1993).
4.4. Acid hydrolyses, derivatization reactions, and determination
of the absolute conﬁgurations of sugars of compounds 1–3
Acid hydrolyses of compounds 1–3 and the derivatization reac-
tions of the obtained sugars, and authentic glucose, were carried
out according to the reported method10,11. Trimethylsilylated
thiazolidine derivatives of the sugars were injected into a GC
system. The sugars, as well as their absolute conﬁgurations, were
determined by comparing the retention times with that of the
trimethylsilylated thiazolidine derivative synthesized from the
authentic glucose. GC conditions in the test was as follows:
capillary column, HP-5 (60 m 0.25 mm, with a 0.25 μm ﬁlm,
Dikma); carrier gas, N2; detection, FID; injection temperature,
260 1C; detection temperature, 280 1C; initial temperature, 16 1C,
raised up to 280 1C at a rate of 5 1C/min and the ﬁnal temperaturewas maintained for 10 min. Along with the NMR examinations,
D-glucose was conﬁrmed to be the only sugar for all 3 compounds.
And under the above analytical conditions, the retention time of
the authentic sugar was at 27.98 min.
4.5. Assay for anti-osteoporotic activity
MG63 cells in the growth phase were dispersed in a 48-well plate
at a density of 5 104 cells/well, and the plate was placed in a
humidiﬁed incubator ﬁlled with 5% CO2 at 37 1C. Plasmid
transfection (0.6 μg/well) was performed for 4 h when the cell
conﬂuence reached 70%–80%. Test compounds at a ﬁnal con-
centration of 10 μmol/L were added into the wells (n¼3) after 4 h
of transfection and were co-incubated for an additional 48 h.
Luciferase activity was detected using a dual luciferase reporter
gene detection kit (Promega, USA).
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